内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Lee Jennifer Kayden. Director active across 1 company, notably Rhythm Pharmaceuticals, INC.. In total, 20 reports have been recorded. Split: 0 buy · 5 sells. Total volume traded: €8.7m. Activity tracked since 7 August 2023. The latest transaction was disclosed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lee Jennifer Kayden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
35,000 股@ US$24.290.011% mcap7.4% 占其流量Common StockSEC:0001649904-26-000009:0
21,601 股@ US$6.800.0018% mcap1.3% 占其流量Common StockSEC:0001649904-26-000009:1
75,834 股@ US$117.38180.11% mcap77.8% 占其流量Common StockSEC:0001649904-26-000009:2
22,612 股Common StockSEC:0001104659-26-009767:0
5,500 股Common StockSEC:0001104659-25-015320:0
600 股@ US$56.392.4% 占其流量Common StockSEC:0001104659-25-014257:0
3,437 股Common StockSEC:0001104659-25-011677:0
1,733 股@ US$60.08117.5% 占其流量Common StockSEC:0001104659-25-010610:0
4,513 股Common StockSEC:0001104659-25-009284:0
20,622 股@ US$6.809.8% 占其流量Common StockSEC:0001104659-24-117942:0
9,169 股@ US$38.2224.1% 占其流量Common StockSEC:0001104659-24-037880:0
15,515 股@ US$39.2241.7% 占其流量Common StockSEC:0001104659-24-036312:0
33,750 股0Common StockSEC:0001104659-24-026154:0
3,438 股Common StockSEC:0001104659-24-022538:0
4,513 股Common StockSEC:0001104659-24-010800:0
12,030 股@ US$6.805.7% 占其流量Common StockSEC:0001104659-23-119095:0
5,712 股@ US$6.802.7% 占其流量Common StockSEC:0001104659-23-117365:0
80 股@ US$6.800.0% 占其流量Common StockSEC:0001104659-23-115368:0
4,519 股@ US$6.802.1% 占其流量Common StockSEC:0001104659-23-099017:0
8,591 股@ US$6.804.0% 占其流量Common StockSEC:0001104659-23-089331:0
About Lee Jennifer Kayden
Lee Jennifer Kayden is a declarant linked to Rhythm Pharmaceuticals, INC., where she holds the role of EVP, Head of North America. The record shows 17 filings in total, and across the 17 sampled filings between 2023-08-09 and 2026-02-03, sales total 1015204 EUR, with Levée d'options as the most frequent transaction nature.